Examiner: GARYU, LIANKO G

Tech Center 1600 • Art Units: 1636 1654 1658 1676

This examiner grants 66% of resolved cases

Performance Statistics

66.0%

Allow Rate

+6.0% vs TC avg

585

Total Applications

+45.2%

Interview Lift

1047

Avg Prosecution Days

Based on 582 resolved cases, 2023–2026

5.9%

§101 Eligibility

22.5%

§102 Novelty

28.3%

§103 Obviousness

30.3%

§112 Clarity

App #	Title	Status	Assignee
17636839	UBE3A FOR THE TREATMENT OF ANGELMAN SYNDROME	Non-Final OA	The Regents of the University of California
19104383	THE USE OF FATTY ALCOHOL POLYGLYCOL ETHER TO REDUCE ENDOTOXIN ACTIVITY AND/OR ENDOTOXINS IN COLLAGEN-CONTAINING AND/OR COLLAGEN-DERIVED PRODUCTS	Non-Final OA	ROUSSELOT B.V.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.